Atopic Dermatitis Research Network – Clinical Research Centers

The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting applications for the Atopic Dermatitis Research Network (ADRN) under solicitation RFA-AI-27-004. This program utilizes a cooperative agreement mechanism to support clinical and translational research centers across the United States. The primary objective is to enhance the understanding of skin immunology and defense mechanisms by analyzing differences between individuals with atopic dermatitis and healthy controls, with a specific focus on chronic skin inflammation. The program supports a range of activities from basic microbial physiology research to collaborative clinical trials of vaccines and experimental drugs, while also providing opportunities for junior investigators to foster research independence. NIAID intends to commit 4,520,000 dollars in FY2027 to fund three to four awards. Individual application budgets are generally expected not to exceed 750,000 dollars in direct costs per year, excluding the Infrastructure and Opportunity Fund (up to 250,000 dollars) and SUNBEAM participation funds (up to 375,000 dollars). Awardees must establish an Administrative Core, a Data Stewardship Core, and at least one Research Project, with optional Clinical and Scientific Cores. Evaluation is based on an overall impact score focusing on the significance of the project and its potential to influence the research field. Applicants must maintain active registrations in SAM, eRA Commons, and Grants.gov, and are limited to one application per institution.